Today: 18 March 2026
Browse Category

Stock Market 20 December 2025

Citigroup Stock (NYSE: C) Hits a New 52‑Week High as Regulatory Pressure Eases: Today’s News, Analyst Forecasts, and What Comes Next (Dec. 20, 2025)

Citigroup Stock (NYSE: C) Hits a New 52‑Week High as Regulatory Pressure Eases: Today’s News, Analyst Forecasts, and What Comes Next (Dec. 20, 2025)

Citigroup shares closed at $114.86 on Dec. 19, hitting a new 52-week high on heavy volume. The move followed news that the Federal Reserve ended certain risk-control notices and the OCC withdrew a 2024 amendment to Citi’s 2020 consent order. Trading volume reached 33.6 million shares, far above average levels. U.S. markets are closed Dec. 20.
20 December 2025
Home Depot Stock (HD) News Today: Price, 2026 Outlook, Analyst Forecasts, and Key Risks as of December 20, 2025

Home Depot Stock (HD) News Today: Price, 2026 Outlook, Analyst Forecasts, and Key Risks as of December 20, 2025

Home Depot shares closed at $345 on December 20, down 2.81% from the prior session and about 19% below their September high. The company reaffirmed 2025 guidance but issued a cautious 2026 outlook at its December investor conference, projecting flat to modest growth and an EPS increase of up to 4%. Analyst expectations remain higher than management’s forecasts.
20 December 2025
Qualcomm Stock (QCOM) News, Forecasts and Analysis for December 20, 2025: Alphawave Semi Deal, Insider Sales, and the 2026 Outlook

Qualcomm Stock (QCOM) News, Forecasts and Analysis for December 20, 2025: Alphawave Semi Deal, Insider Sales, and the 2026 Outlook

Qualcomm closed at $175.25 on Friday, up 0.61%, and ticked higher to $175.75 after hours. The company’s $2.4 billion Alphawave Semi acquisition drew attention as it moves further into data center infrastructure. Shares have traded between $120.80 and $205.95 over the past year. KMG Fiduciary Partners raised its stake by 3.1% in Q3.
20 December 2025
Exxon Mobil Stock (XOM) Today: 2030 Plan Upgrade, Buyback Outlook and Analyst Forecasts as Oil Slips Below $60

Exxon Mobil Stock (XOM) Today: 2030 Plan Upgrade, Buyback Outlook and Analyst Forecasts as Oil Slips Below $60

Exxon Mobil closed at $116.69 on December 19, 2025, after a volatile week as oil prices hovered near multi-year lows, with Brent at $60.47 and WTI at $56.66 per barrel. The company raised its 2030 earnings and cash flow targets without increasing capex. CFO Kathy Mikells will retire in February, with Neil Hansen set to replace her. Exxon is also eyeing Lukoil’s international assets amid ongoing sanctions.
20 December 2025
Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

Salesforce shares closed at $259.91 on Dec. 19, up 0.8%, with about 20.7 million shares traded. The stock remains far below its 52-week high, as investors weigh AI growth prospects against weak SaaS sentiment. Q3 FY2026 revenue rose 9% to $10.3 billion, with Agentforce + Data 360 annual recurring revenue up 114% to $1.4 billion. Salesforce raised its full-year revenue outlook to $41.45–$41.55 billion.
Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston shares plunged nearly 26% Friday after management warned of continued discounting and higher international costs despite beating Q2 FY2026 earnings expectations. Net sales rose 1% to $1.618 billion, with an 8% volume gain offset by an 8% drop in price/mix. The company said margin pressure may persist into the second half of the year.
Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

U.S. antitrust agencies have cleared Nvidia’s investment in Intel, removing a major regulatory hurdle for the partnership, according to the FTC. Intel shares traded near $36.82 early Saturday, with heavier-than-normal volume. The Nvidia deal is seen as a reputational boost for Intel, but investors remain focused on execution and foundry progress.
20 December 2025
Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital shares jumped 16.53% to $27.85 on Friday, Dec. 19, rebounding after a midweek drop tied to debt concerns in the AI data center sector. The rally followed news of a $100 million development loan facility with Macquarie Group and renewed optimism in AI infrastructure stocks after Micron’s results.
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly shares closed at $1,071.44 on Dec. 19, near record highs, after reporting positive Phase 3 results for its oral weight-loss drug orforglipron. The company also cut prices on Zepbound and Mounjaro in the U.S. and Canada. Lilly’s market value surpassed $1 trillion this year amid growing demand for obesity and cardiometabolic treatments.
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin shares jumped 17.7% to $61.15 Friday after announcing a $4.8 billion all-cash deal to acquire Amicus Therapeutics at $14.50 per share. The acquisition adds two marketed rare-disease drugs and a Phase 3 asset, and resolves U.S. patent litigation over Galafold, delaying generic entry to 2037. BioMarin expects the deal to close in Q2 2026 and be accretive to earnings within a year.
Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival shares jumped 9.8% to $31.12 Friday after the company reported record 2025 profit of $2.8 billion and revenue of $26.6 billion. The board reinstated a quarterly dividend at $0.15 per share, the first since 2020. Carnival also proposed unifying its dual-listed structure and moving its legal domicile to Bermuda. Guidance for 2026 calls for further earnings growth.
Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings shares surged 18.2% to $9.22 on December 19, with trading volume hitting 125 million. The move followed a series of defense-focused announcements, including a new COO appointment and the completed acquisition of Roboteam. Analyst coverage has increased, while SEC filings show new share issuance and a significant non-cash charge.
Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research shares jumped 4.6% to $172.27 on Dec. 19, hitting a new high after a series of analyst upgrades and price-target increases tied to AI and memory chip demand. Deutsche Bank and B. Riley raised targets to $195, while Mizuho and Oppenheimer set targets at $200. Trading volume surged to 38.47 million shares. Markets were closed on Dec. 20.
20 December 2025
Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco shares closed Friday at $78.42, up 1.91%, after heavy trading pushed the stock near its all-time high set during the dot-com era. Morgan Stanley raised its price target to $91 on Dec. 17, citing AI infrastructure demand. Jackson Square Capital increased its stake in Cisco during the third quarter. The company faces scrutiny over a newly disclosed high-severity cybersecurity issue.
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave shares surged 22.5% to about $83 in heavy trading after Citigroup resumed coverage with a Buy rating and the U.S. Department of Energy named the company as a Genesis Mission partner. Citi lowered its price target to $135 and flagged “High Risk,” citing strong demand but operational challenges. The stock had dropped 65% from its June high after its March IPO.
Seagate Technology (STX) Stock Today (Dec. 20, 2025): Nasdaq-100 Catalyst, AI Storage Demand, Dividend, and Wall Street Forecasts

Seagate Technology (STX) Stock Today (Dec. 20, 2025): Nasdaq-100 Catalyst, AI Storage Demand, Dividend, and Wall Street Forecasts

Seagate shares traded near $296 on Dec. 20, 2025, after a volatile year marked by a 200% surge tied to AI-driven storage demand. The company is set to join the Nasdaq-100 on Dec. 22, prompting traders to position for index-related flows. Institutional ownership stands at about 92.9%, with new positions reported by U.S. Capital Wealth Advisors. Analyst targets remain divided as Seagate posts record margins and strong guidance.
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

BioMarin Pharmaceutical agreed to acquire Amicus Therapeutics in an all-cash deal valued at about $4.8 billion, offering $14.50 per share. Amicus stock jumped roughly 30% to $14.18 on heavy volume, trading just below the bid as investors assess deal closure risks. Both boards approved the transaction, with closing targeted for Q2 2026 pending shareholder and regulatory approvals.
DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

Trump Media & Technology Group announced an all-stock merger with nuclear fusion firm TAE Technologies, valuing the deal at over $6 billion. DJT shares surged more than 40% on Dec. 18, trading around $16 amid high volatility. The combined company will split ownership evenly between shareholders and target a utility-scale fusion plant. Trump Media CEO Devin Nunes and TAE’s Michl Binderbauer will serve as co-CEOs.

Stock Market Today

  • US Stocks Rise on March 18 Despite Middle East Tensions and High Oil Prices
    March 18, 2026, 8:26 AM EDT. U.S. stock markets closed higher on March 18, 2026, ignoring elevated crude oil prices amid ongoing Middle East conflict. The Dow Jones Industrial Average edged up 0.1% to 46,993.26, while the Nasdaq Composite gained 0.5%, boosted by tech giant Western Digital's 9.6% jump. The S&P 500 rose 0.3%, with all 11 sectors advancing. The CBOE Volatility Index (VIX), a measure of market fear, dropped 4.9% to 22.37. Despite geopolitical tensions and oil supply disruptions, investors awaited the Federal Reserve's interest rate decision from its FOMC meeting. Market consensus heavily favors stable rates between 3.5-3.75%, with only mild probability of a hike.
Go toTop